Addiction Research and Treatment Corporation

Addiction Research and Treatment Corporation
Name	Addiction Research and Treatment Corporation
Formation	1970s
Type	Non-profit healthcare organization
Headquarters	New York City
Services	Substance use disorder treatment, medication-assisted treatment, counseling, research
Leader title	CEO

Contents

Addiction Research and Treatment Corporation

Addiction Research and Treatment Corporation is a non-profit healthcare organization based in New York City providing substance use disorder services, research, and community programs. The organization interfaces with institutions such as New York University, Columbia University, Mount Sinai Health System, Bellevue Hospital Center, and Weill Cornell Medicine while operating clinics and participating in trials with partners like National Institutes of Health, Substance Abuse and Mental Health Services Administration, and City of New York agencies. Its work touches policy actors including New York State Department of Health, Centers for Disease Control and Prevention, and advocacy groups like American Society of Addiction Medicine and Harm Reduction Coalition.

History

Founded in the 1970s amid rising public attention to opioid dependence and substance use, the organization developed links to academic centers including Syracuse University, Fordham University, Hunter College, and Johns Hopkins University for training and program development. Early collaborations involved clinicians from Albert Einstein College of Medicine, researchers from Yale University, and policy advisors with connections to Harvard Medical School and Columbia University Mailman School of Public Health. Over decades the entity expanded services following models promoted by Rockefeller University-affiliated researchers and initiatives inspired by programs at Beth Israel Medical Center and Montefiore Medical Center. Regulatory environments shaped its operations through interactions with Food and Drug Administration, New York State Office of Alcoholism and Substance Abuse Services, and municipal leaders from New York City Department of Health and Mental Hygiene. Significant moments in institutional development paralleled national events such as the War on Drugs, the passage of the Drug Addiction Treatment Act of 2000, and shifts during the HIV/AIDS epidemic affecting harm reduction practices.

The organization provides medication-assisted treatment informed by trials at Massachusetts General Hospital, counseling approaches derived from studies at University of Pennsylvania, and integrated care models used at Kaiser Permanente. Programs include outpatient clinics, mobile units, and inpatient referrals coordinated with Metropolitan Hospital Center, NewYork-Presbyterian Hospital, and community providers like Riverdale Family Health Association. It offers screening and linkage services similar to protocols developed at Montefiore Medical Center and St. Luke's–Roosevelt Hospital Center and runs prevention outreach informed by collaborations with Johns Hopkins Bloomberg School of Public Health and Yale School of Medicine. Training programs involve partnerships with residency programs at SUNY Downstate Medical Center, fellowship tracks akin to those at Rutgers Biomedical Health Sciences, and workforce development with organizations such as The New York Academy of Medicine.

The corporation participates in clinical trials modeled after those at National Institute on Drug Abuse, Columbia University Irving Medical Center, and Vanderbilt University Medical Center. Research topics include pharmacotherapy trials paralleling work at Johns Hopkins University School of Medicine, behavioral interventions influenced by studies at University of California, Los Angeles, and epidemiologic surveillance similar to projects at Centers for Disease Control and Prevention. Collaborative publications have involved investigators from University of Michigan, Dartmouth College, Brown University, and Emory University School of Medicine. It has sought grant support from entities such as National Science Foundation and foundations like Robert Wood Johnson Foundation and Gates Foundation-funded initiatives addressing public health responses.

Governance includes a board with professionals recruited from institutions like Weill Cornell Medicine, Columbia University, and Mount Sinai Health System and executive leadership with experience in nonprofit management similar to leaders from New York Community Trust and Robin Hood Foundation. Funding streams have included federal grants from Health Resources and Services Administration, state contracts through New York State Department of Health, private foundation awards from Carnegie Corporation of New York, and philanthropic donations linked to families with ties to Rockefeller Foundation and corporate partners comparable to Pfizer and Johnson & Johnson in clinical support. Billing relationships involve payers such as Medicaid managed through state arrangements and insurer collaborations like Aetna and Cigna for contracted services.

The organization has navigated regulatory scrutiny similar to cases involving other treatment providers referenced in litigation with entities such as New York State Attorney General offices and oversight bodies like Office of Inspector General (United States Department of Health and Human Services). Concerns reported in the sector—mirrored in media coverage involving outlets such as The New York Times, The Wall Street Journal, and ProPublica—have included billing practices, compliance with federal research regulations, and clinical governance issues. Legal proceedings in comparable settings have involved settlements with agencies like Department of Justice and consent decrees overseen by United States District Court for the Southern District of New York in analogous matters across the field.

Community outreach includes syringe-access efforts paralleling programs by Harm Reduction Coalition and partnership with municipal initiatives such as New York Cares and NYC Health + Hospitals collaborations. Educational campaigns have been coordinated with schools and community centers associated with Bronx Community College, Queens College, and cultural institutions like Brooklyn Public Library and New York Public Library. The organization’s influence is visible in workforce training pipelines with Columbia University School of Nursing, internship programs with City University of New York, and policy contributions to advisory panels convened by United Nations Office on Drugs and Crime and state task forces following recommendations from Surgeon General of the United States reports.

Category:Health charities in the United States Category:Addiction organizations in the United States